NOREPINEPHRINE BITARTRATE

Generic: NOREPINEPHRINE BITARTRATE

AvenacyManufacturer
INTRAVENOUSRoute
NOREPINEPHRINE BITARTRATEActive Substance
2025-11-25Original Approval

NOREPINEPHRINE BITARTRATE is FDA application ANDA219924, sponsored by ANTHEA PHARMA. Any recalls listed below come from FDA drug enforcement reports, and reaction counts are the number of FAERS adverse event reports that mention the drug and that reaction; a report does not prove the drug caused it.

Recalls

Top Reported Reactions

1
DRUG INEFFECTIVE
452 reports
2
CONDITION AGGRAVATED
357 reports
3
OFF LABEL USE
316 reports
4
HYPOTENSION
291 reports
5
MULTIPLE ORGAN DYSFUNCTION SYNDROME
286 reports
6
SEPSIS
268 reports
7
CARDIOGENIC SHOCK
233 reports
8
STRESS
229 reports
9
GENERAL PHYSICAL HEALTH DETERIORATION
215 reports
10
HYPONATRAEMIA
201 reports